Eosinophilic fascitis: a report of two cases treated with ultraviolet A1 phototherapy.
Eosinophilic fascitis (EF) (synonyms: Shulman's syndrome, diffuse fascitis with eosinophilia) is a disease characterized by a complex set of symptoms with scleroderma-like skin lesions, the absence of Raynaud's phenomenon and other non-mandatory symptoms including eosinophilia, elevated erythrocyte sedimentation rate, hypergammaglobulinemia and high levels of circulating immune complexes. EF is probably not a separate disease entity, but an acute variant of localized scleroderma. This rare disease of unknown etiology is usually seen in middle-aged adults. Sclerodermiform indurations without Raynaud's symptoms develop rapidly usually on the extremities and more rarely on the trunk or the face. The skin becomes hard, tightly bound to the underlying structures, so that contractures can develop in as little as a few weeks. The course of the disease is usually chronic but spontaneous remission is possible. Standard therapy includes high doses of corticosteroids, immunosuppressive drugs such as methotrexate, cyclosporin A, cyclophosphamide or azathioprine and others such as psoralen and ultraviolet A radiation.
Silny
Wojciech
W
Department of Dermatology, University of Medical Science, Poznan, Poland. wsilny@ump.edu.pl
Osmola-Mankowska
Agnieszka
A
Czarnecka-Operacz
Magdalena
M
Zaba
Ryszard
R
Danczak-Pazdrowska
Aleksandra
A
Marciniak
Adrianna
A
D000328:Adult; D004802:Eosinophilia / Q000532:radiotherapy*; D005208:Fasciitis / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D014467:Ultraviolet Therapy